相关实验视频

Updated: Jan 18, 2026

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

器官作为预测平台:推进疾病建模,治疗创新和药物输送系统

Ting Huang¹, Weitao Huang², Qiong Bian²

¹Center for Plastic & Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang, China; Public Technology Service Platform, Wuhan Institute of Biotechnology, Wuhan, Hubei, 430075, China; Wuhan Biobank Co., Ltd, Wuhan, Hubei, 430075, China.

Journal of controlled release : official journal of the Controlled Release Society

|September 12, 2025

概括

有机器人是改造生物医学研究的先进3D模型. 工程和应用方面的创新增强了疾病建模,药物评估和精准医学.

科学领域:

生物医学研究生物医学研究
组织工程是组织工程.
再生医学是一种再生医学.

背景情况:

三维 (3D) 有机体为生物医学研究提供了生理学上相关的模型.
有机器人回顾组织架构,疾病异质性和患者特异性反应.
它们正在彻底改变从疾病建模到精准医学的应用.

研究的目的:

审查工程器官的最新进展.
为了总结有机体的多面生物医学应用.
强调有机体在推进药物输送系统中的作用.

主要方法:

微流体,基因编辑,生物打印和人工智能的整合用于有机体工程.
用于药物输送系统的有机物质的验证 (准效率,疗效,安全性).
对有机体发展的挑战和未来战略的分析.

主要成果:

工程进步提高了微环境控制,功能成熟和有机体的可扩展性.
在疾病建模,再生医学,药物评估和精确瘤学中,有机器人具有广泛的应用.
器官类药物在验证药物输送系统的向,有效性和安全性方面是有效的.

结论:

通过跨学科创新,机器人技术正在迅速发展.
解决血管化,免疫整合和标准化方面的挑战至关重要.
有机器人具有重塑生物医学未来的巨大潜力.

关键词:

药物输送系统是药物输送系统.药物评估药物评估器官类动物器官类动物在芯片上安装器官精准医学是一门精准的医学.

更多相关视频

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality

Published on: May 5, 2022

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications

Published on: March 8, 2024

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...